Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Altimmune (ALT) Return on Invested Capital: 2017-2025

Historic Return on Invested Capital for Altimmune (ALT) over the last 3 years, with Mar 2025 value amounting to -0.73%.

  • Altimmune's Return on Invested Capital was N/A to -0.73% in Q1 2025 from the same period last year, while for Mar 2025 it was -0.73%, marking a year-over-year change of. This contributed to the annual value of -0.45% for FY2022, which is N/A change from last year.
  • As of Q1 2025, Altimmune's Return on Invested Capital stood at -0.73%, which was down 68.51% from -0.43% recorded in Q3 2022.
  • In the past 5 years, Altimmune's Return on Invested Capital registered a high of -0.43% during Q3 2022, and its lowest value of -0.73% during Q1 2025.
  • Its 1-year average for Return on Invested Capital is -0.73%, with a median of -0.73% in 2025.